J Biol Chem 261: 11880-11889, 1986
We additionally accounted for sex, race, ethnicity, BMI prior to starting the GLP-1, change in BMI upon starting the GLP-1 as well as throughout their usage, use of osteoporosis medications, steroid use, smoking history, and comorbidities including hyperparathyroidism, chronic falls, cancer, CKD, malabsorption, IBD, and eating disorders in our analysis
Discontinuing peptide therapy often leads to weight regain
Moisture should be carefully managed to preserve texture, prevent microbial growth, and protect active ingredient potency over the products intended shelf life
& Awad, E